Elisabetta Molteni
Udine, 33100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Improved Surfactant-Assisted One-Pot Sample Preparation for Robust Convenient Single-Cell Proteomics.
Journal: Journal of proteome research
Published: July 10, 2026
Time-varying hazard rates reveal patterns of progression in HR+/HER2- metastatic breast cancer: Towards risk-adapted monitoring.
Journal: Translational oncology
Published: July 06, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.
Journal: Science translational medicine
Published: March 11, 2026
Improved surfactant-assisted one-pot sample preparation for robust convenient single cell proteomics.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2026
Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.
Journal: Breast (Edinburgh, Scotland)
Published: June 24, 2025
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics.
Journal: Translational oncology
Published: December 15, 2024
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis.
Journal: NPJ breast cancer
Published: November 18, 2024
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?
Journal: Expert review of anticancer therapy
Published: June 10, 2024
Cellular residual disease (CRD) in early breast cancer -Expanding the concept of minimal residual disease monitoring?
Journal: The journal of liquid biopsy
Published: October 18, 2023
Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications.
Journal: The journal of liquid biopsy
Published: September 06, 2023
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer.
Journal: Cancer discovery
Published: May 19, 2023
Last Updated: 09/26/2026